BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serafini A, Gerard E, Genton P, Crespel A, Gelisse P. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential. CNS Drugs 2019;33:195-208. [PMID: 30747367 DOI: 10.1007/s40263-018-00602-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Nilo A, Gelisse P, Crespel A. Genetic/idiopathic generalized epilepsies: Not so good as that! Revue Neurologique 2020;176:427-38. [DOI: 10.1016/j.neurol.2020.03.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Turco F, Bonanni E, Milano C, Pizzanelli C, Steinwurzel C, Morganti R, Fornai F, Maestri M, Siciliano G, Giorgi FS. Prolonged epileptic discharges predict seizure recurrence in JME: Insights from prolonged ambulatory EEG. Epilepsia 2021;62:1184-92. [PMID: 33735449 DOI: 10.1111/epi.16875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cerulli Irelli E, Morano A, Cocchi E, Casciato S, Fanella M, Albini M, Avorio F, Basili LM, Fisco G, Barone FA, Mascia A, D’aniello A, Manfredi M, Fattouch J, Quarato P, Giallonardo AT, Di Gennaro G, Di Bonaventura C. Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome. Epilepsia 2020;61:107-14. [DOI: 10.1111/epi.16407] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
4 Gürer R, Aydın Ş, Özkara Ç. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy. Seizure 2019;70:43-8. [PMID: 31252363 DOI: 10.1016/j.seizure.2019.06.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Milano C, Turco F, Pizzanelli C, Bonanni E, Siciliano G, Fornai F, Giorgi FS. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study. Epilepsy Behav 2021;115:107706. [PMID: 33423017 DOI: 10.1016/j.yebeh.2020.107706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Liu J, Tai YJ, Wang LN. Topiramate for juvenile myoclonic epilepsy. Cochrane Database Syst Rev 2021;11:CD010008. [PMID: 34817852 DOI: 10.1002/14651858.CD010008.pub5] [Reference Citation Analysis]
7 Cerulli Irelli E, Morano A, Orlando B, Salamone EM, Fanella M, Fattouch J, Manfredi M, Giallonardo AT, Di Bonaventura C. Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients. Acta Neurol Scand 2021. [PMID: 34791656 DOI: 10.1111/ane.13556] [Reference Citation Analysis]
8 Eadie MJ. Pregnancy and the Control of Epileptic Seizures: A Review. Neurol Ther 2021. [PMID: 33988822 DOI: 10.1007/s40120-021-00252-5] [Reference Citation Analysis]
9 Chen RH, Li BF, Wen JH, Zhong CL, Ji MM. Clinical and electroencephalogram characteristics and treatment outcomes in children with benign epilepsy and centrotemporal spikes. World J Clin Cases 2021; 9(33): 10116-10125 [PMID: 34904081 DOI: 10.12998/wjcc.v9.i33.10116] [Reference Citation Analysis]